BUND FINANCE

BUND FINANCE › Stocks › RMD

ResMed Inc. (RMD)

NYSE · Stock price, chart and technical analysis

US$236.88-5.73 (-2.36%)

Data from Financial Modeling Prep · Nov 19, 2026, 4:00 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$242.61
OpenUS$242.48
Day rangeUS$235.98 – US$242.99
52-week rangeUS$180.27 – US$277.67
Market capUS$33.32B
Volume1.14M
50-day averageUS$233.14
200-day averageUS$223.64
Beta0.76
Last dividend per shareUS$2.52

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20222023202420252026
RevenueUS$3.6BUS$4.2BUS$4.7BUS$5.1BUS$5.7B
Net incomeUS$779.4MUS$897.6MUS$1.0BUS$1.4BUS$1.5B
EPS (diluted)5.306.096.929.5110.40
Gross margin56.6%55.8%56.7%59.4%61.1%
Operating margin28.0%26.8%28.2%32.8%33.8%
Net margin21.8%21.3%21.8%27.2%26.9%
Free cash flowUS$195.1MUS$559.3MUS$1.3BUS$1.7BUS$1.6B
Total debtUS$917.6MUS$1.6BUS$873.9MUS$851.8MUS$825.9M
CashUS$273.7MUS$227.9MUS$238.4MUS$1.2BUS$1.5B

Compound annual growth: revenue 12.1% · net income 18.2% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E21.6x29.5x26.4x
EV / EBITDA14.7x20.4x16.3x
Operating margin33.1%—3.6%
Net margin27.8%—-0.0%
Debt / equity0.38—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.

About ResMed Inc.

SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryUS
CEOMichael J. Farrell
Employees11,370
IPO date1995-06-02

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable sof…

www.resmed.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice